Biotech Updates

PBL Awarded Pioneering US Patent on RNAi

January 20, 2012

The Plant Bioscience Limited (PBL) announced the granting of a US patent to the RNAi technology. Series of patents on this technology have been issued since 2004. Issuance of this newest patent acknowledges the role of short RNA molecules as the common mediators of gene silencing in different species and organisms, and protects the use of short RNAs for the purpose of inducing the silencing of a target gene in a cell.

PBL's Managing Director, Dr Jan Chojecki, states "We are very pleased that our efforts in working with the US Patent Office have resulted in issuance of this patent. It is an excellent example of how innovations in a specialized field can, once recognized, have impact across many other areas of research, discovery and beneficial application. It is also a tribute to the quality of fundamental research carried out in public research laboratories in the United Kingdom."

Details of the news and other patents on the RNAi technology can be viewed at http://www.pbltechnology.com/documents/News%20Documents/SHORT%20RNA%20PRESS%20RELEASE%2099.190%2017.01.12%20for%20PDF.pdf